Staff donations through the Small Change: Big Impact scheme will this year support the University’s research into the early detection of cancer.
Appears in Issue 64
The NHS in Scotland is to conduct a major screening trial for lung cancer using a new blood test developed by Oncimmune Ltd, a University of Nottingham spinout company. It will be the first time the blood test has been used outside the US.
Appears in issue 57